UTHR Annual Net Income
$984.80 M
+$257.50 M+35.40%
31 December 2023
Summary:
As of January 22, 2025, UTHR annual net profit is $984.80 million, with the most recent change of +$257.50 million (+35.40%) on December 31, 2023. During the last 3 years, it has risen by +$470.00 million (+91.30%). UTHR annual net income is now at all-time high.UTHR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Quarterly Net Income
$309.10 M
+$31.00 M+11.15%
30 September 2024
Summary:
As of January 22, 2025, UTHR quarterly net profit is $309.10 million, with the most recent change of +$31.00 million (+11.15%) on September 30, 2024. Over the past year, it has increased by +$41.50 million (+15.51%). UTHR quarterly net income is now -33.44% below its all-time high of $464.40 million, reached on September 30, 2015.UTHR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR TTM Net Income
$1.11 B
+$41.50 M+3.88%
30 September 2024
Summary:
As of January 22, 2025, UTHR TTM net profit is $1.11 billion, with the most recent change of +$41.50 million (+3.88%) on September 30, 2024. Over the past year, it has increased by +$211.10 million (+23.46%). UTHR TTM net income is now at all-time high.UTHR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.4% | +15.5% | +23.5% |
| 3 y3 years | +91.3% | +15.5% | +23.5% |
| 5 y5 years | +67.1% | +124.5% | +110.5% |
UTHR Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +107.0% | at high | +175.5% | at high | +133.5% |
| 5 y | 5-year | at high | +1042.4% | at high | +992.2% | at high | +1163.1% |
| alltime | all time | at high | +1042.4% | -33.4% | +162.5% | at high | +841.1% |
United Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $309.10 M(+11.1%) | $1.11 B(+3.9%) |
| June 2024 | - | $278.10 M(-9.3%) | $1.07 B(+1.8%) |
| Mar 2024 | - | $306.60 M(+41.2%) | $1.05 B(+6.7%) |
| Dec 2023 | $984.80 M(+35.4%) | $217.10 M(-18.9%) | $984.80 M(+9.4%) |
| Sept 2023 | - | $267.60 M(+3.2%) | $899.80 M(+3.2%) |
| June 2023 | - | $259.20 M(+7.6%) | $871.50 M(+19.7%) |
| Mar 2023 | - | $240.90 M(+82.4%) | $728.30 M(+0.1%) |
| Dec 2022 | $727.30 M(+52.9%) | $132.10 M(-44.8%) | $727.30 M(+2.8%) |
| Sept 2022 | - | $239.30 M(+106.3%) | $707.40 M(+12.1%) |
| June 2022 | - | $116.00 M(-51.6%) | $630.80 M(-8.2%) |
| Mar 2022 | - | $239.90 M(+113.8%) | $687.40 M(+44.5%) |
| Dec 2021 | $475.80 M(-7.6%) | $112.20 M(-31.0%) | $475.80 M(+2.9%) |
| Sept 2021 | - | $162.70 M(-5.7%) | $462.40 M(-1.8%) |
| June 2021 | - | $172.60 M(+509.9%) | $470.90 M(+16.2%) |
| Mar 2021 | - | $28.30 M(-71.4%) | $405.40 M(-21.3%) |
| Dec 2020 | $514.80 M(-592.6%) | $98.80 M(-42.3%) | $514.80 M(+9.9%) |
| Sept 2020 | - | $171.20 M(+59.9%) | $468.60 M(+9.0%) |
| June 2020 | - | $107.10 M(-22.2%) | $429.80 M(-18.6%) |
| Mar 2020 | - | $137.70 M(+161.8%) | $527.80 M(-605.1%) |
| Dec 2019 | -$104.50 M(-117.7%) | $52.60 M(-60.3%) | -$104.50 M(+13.8%) |
| Sept 2019 | - | $132.40 M(-35.4%) | -$91.80 M(-22.0%) |
| June 2019 | - | $205.10 M(-141.5%) | -$117.70 M(-21.5%) |
| Mar 2019 | - | -$494.60 M(-857.4%) | -$149.90 M(-125.4%) |
| Dec 2018 | $589.20 M(+41.0%) | $65.30 M(-38.7%) | $589.20 M(+8.5%) |
| Sept 2018 | - | $106.50 M(-38.4%) | $542.90 M(-23.8%) |
| June 2018 | - | $172.90 M(-29.3%) | $712.70 M(+47.3%) |
| Mar 2018 | - | $244.50 M(+1186.8%) | $483.80 M(+15.8%) |
| Dec 2017 | $417.90 M(-41.4%) | $19.00 M(-93.1%) | $417.90 M(-17.9%) |
| Sept 2017 | - | $276.30 M(-593.4%) | $509.20 M(+29.0%) |
| June 2017 | - | -$56.00 M(-131.4%) | $394.70 M(-39.9%) |
| Mar 2017 | - | $178.60 M(+61.9%) | $656.80 M(-8.0%) |
| Dec 2016 | $713.70 M(+9.5%) | $110.30 M(-31.8%) | $713.70 M(+0.8%) |
| Sept 2016 | - | $161.80 M(-21.5%) | $708.00 M(-29.9%) |
| June 2016 | - | $206.10 M(-12.5%) | $1.01 B(+11.8%) |
| Mar 2016 | - | $235.50 M(+125.1%) | $903.70 M(+38.7%) |
| Dec 2015 | $651.60 M(+91.6%) | $104.60 M(-77.5%) | $651.60 M(-1.7%) |
| Sept 2015 | - | $464.40 M(+368.1%) | $662.96 M(+282.5%) |
| June 2015 | - | $99.20 M(-697.6%) | $173.32 M(-6.8%) |
| Mar 2015 | - | -$16.60 M(-114.3%) | $185.98 M(-45.3%) |
| Dec 2014 | $340.10 M(+94.8%) | $115.96 M(-559.5%) | $340.10 M(+75.5%) |
| Sept 2014 | - | -$25.24 M(-122.6%) | $193.82 M(-31.2%) |
| June 2014 | - | $111.85 M(-18.7%) | $281.75 M(+12.8%) |
| Mar 2014 | - | $137.52 M(-553.7%) | $249.76 M(+43.1%) |
| Dec 2013 | $174.56 M(-42.7%) | -$30.31 M(-148.4%) | $174.56 M(-39.4%) |
| Sept 2013 | - | $62.69 M(-21.5%) | $288.13 M(-5.1%) |
| June 2013 | - | $79.86 M(+28.1%) | $303.56 M(+2.5%) |
| Mar 2013 | - | $62.33 M(-25.1%) | $296.01 M(-2.8%) |
| Dec 2012 | $304.44 M(+39.7%) | $83.25 M(+6.6%) | $304.44 M(+15.2%) |
| Sept 2012 | - | $78.11 M(+8.0%) | $264.38 M(-2.3%) |
| June 2012 | - | $72.32 M(+2.2%) | $270.66 M(-0.6%) |
| Mar 2012 | - | $70.76 M(+63.8%) | $272.24 M(+25.0%) |
| Dec 2011 | $217.87 M | $43.19 M(-48.8%) | $217.87 M(+18.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $84.40 M(+14.2%) | $184.22 M(+32.0%) |
| June 2011 | - | $73.89 M(+350.8%) | $139.56 M(+35.0%) |
| Mar 2011 | - | $16.39 M(+71.7%) | $103.38 M(-2.4%) |
| Dec 2010 | $105.92 M(+444.2%) | $9.54 M(-76.0%) | $105.92 M(+13.8%) |
| Sept 2010 | - | $39.74 M(+5.4%) | $93.04 M(+42.6%) |
| June 2010 | - | $37.71 M(+99.2%) | $65.24 M(+159.0%) |
| Mar 2010 | - | $18.93 M(-668.4%) | $25.19 M(+29.5%) |
| Dec 2009 | $19.46 M(-139.5%) | -$3.33 M(-127.9%) | $19.46 M(-132.8%) |
| Sept 2009 | - | $11.94 M(-609.3%) | -$59.28 M(-1.6%) |
| June 2009 | - | -$2.34 M(-117.8%) | -$60.25 M(+38.3%) |
| Mar 2009 | - | $13.20 M(-116.1%) | -$43.57 M(-4.0%) |
| Dec 2008 | -$49.33 M(-348.4%) | -$82.07 M(-848.1%) | -$45.37 M(-217.3%) |
| Sept 2008 | - | $10.97 M(-23.5%) | $38.69 M(-9.1%) |
| June 2008 | - | $14.33 M(+25.7%) | $42.57 M(+25.0%) |
| Mar 2008 | - | $11.40 M(+474.2%) | $34.04 M(+71.4%) |
| Dec 2007 | $19.86 M(-73.2%) | $1.99 M(-86.6%) | $19.86 M(-72.9%) |
| Sept 2007 | - | $14.85 M(+155.7%) | $73.38 M(+9.5%) |
| June 2007 | - | $5.81 M(-308.8%) | $67.01 M(-2.7%) |
| Mar 2007 | - | -$2.78 M(-105.0%) | $68.88 M(-6.9%) |
| Dec 2006 | $73.97 M(+13.8%) | $55.51 M(+554.7%) | $73.97 M(+54.5%) |
| Sept 2006 | - | $8.48 M(+10.5%) | $47.87 M(-13.2%) |
| June 2006 | - | $7.67 M(+232.6%) | $55.15 M(-7.6%) |
| Mar 2006 | - | $2.31 M(-92.2%) | $59.66 M(-8.2%) |
| Dec 2005 | $65.02 M(+320.8%) | $29.41 M(+86.6%) | $65.02 M(+53.0%) |
| Sept 2005 | - | $15.76 M(+29.4%) | $42.49 M(+28.8%) |
| June 2005 | - | $12.18 M(+59.0%) | $33.00 M(+32.2%) |
| Mar 2005 | - | $7.66 M(+11.2%) | $24.96 M(+61.5%) |
| Dec 2004 | $15.45 M(-255.0%) | $6.89 M(+10.0%) | $15.45 M(+189.4%) |
| Sept 2004 | - | $6.27 M(+51.4%) | $5.34 M(-335.4%) |
| June 2004 | - | $4.14 M(-324.1%) | -$2.27 M(-74.2%) |
| Mar 2004 | - | -$1.85 M(-42.6%) | -$8.79 M(-11.8%) |
| Dec 2003 | -$9.97 M(-57.8%) | -$3.22 M(+140.1%) | -$9.97 M(+6.6%) |
| Sept 2003 | - | -$1.34 M(-43.8%) | -$9.35 M(-53.7%) |
| June 2003 | - | -$2.38 M(-21.2%) | -$20.20 M(-3.8%) |
| Mar 2003 | - | -$3.02 M(+16.1%) | -$21.00 M(-11.2%) |
| Dec 2002 | -$23.65 M(-36.6%) | -$2.60 M(-78.6%) | -$23.65 M(-16.9%) |
| Sept 2002 | - | -$12.19 M(+283.3%) | -$28.47 M(+9.1%) |
| June 2002 | - | -$3.18 M(-44.0%) | -$26.10 M(-22.2%) |
| Mar 2002 | - | -$5.68 M(-23.6%) | -$33.56 M(-10.0%) |
| Dec 2001 | -$37.29 M(-50.7%) | -$7.43 M(-24.3%) | -$37.29 M(-39.6%) |
| Sept 2001 | - | -$9.81 M(-7.9%) | -$61.73 M(+4.7%) |
| June 2001 | - | -$10.65 M(+13.2%) | -$58.94 M(-23.6%) |
| Mar 2001 | - | -$9.40 M(-70.5%) | -$77.10 M(+2.0%) |
| Dec 2000 | -$75.61 M(+125.7%) | -$31.87 M(+354.4%) | -$75.61 M(+43.9%) |
| Sept 2000 | - | -$7.01 M(-75.7%) | -$52.54 M(+1.2%) |
| June 2000 | - | -$28.81 M(+264.2%) | -$51.92 M(+77.7%) |
| Mar 2000 | - | -$7.91 M(-10.1%) | -$29.21 M(-12.8%) |
| Dec 1999 | -$33.50 M(+161.7%) | -$8.80 M(+37.5%) | -$33.50 M(+35.6%) |
| Sept 1999 | - | -$6.40 M(+4.9%) | -$24.70 M(+35.0%) |
| June 1999 | - | -$6.10 M(-50.0%) | -$18.30 M(+50.0%) |
| Mar 1999 | - | -$12.20 M | -$12.20 M |
| Dec 1998 | -$12.80 M | - | - |
FAQ
- What is United Therapeutics annual net profit?
- What is the all time high annual net income for United Therapeutics?
- What is United Therapeutics annual net income year-on-year change?
- What is United Therapeutics quarterly net profit?
- What is the all time high quarterly net income for United Therapeutics?
- What is United Therapeutics quarterly net income year-on-year change?
- What is United Therapeutics TTM net profit?
- What is the all time high TTM net income for United Therapeutics?
- What is United Therapeutics TTM net income year-on-year change?
What is United Therapeutics annual net profit?
The current annual net income of UTHR is $984.80 M
What is the all time high annual net income for United Therapeutics?
United Therapeutics all-time high annual net profit is $984.80 M
What is United Therapeutics annual net income year-on-year change?
Over the past year, UTHR annual net profit has changed by +$257.50 M (+35.40%)
What is United Therapeutics quarterly net profit?
The current quarterly net income of UTHR is $309.10 M
What is the all time high quarterly net income for United Therapeutics?
United Therapeutics all-time high quarterly net profit is $464.40 M
What is United Therapeutics quarterly net income year-on-year change?
Over the past year, UTHR quarterly net profit has changed by +$41.50 M (+15.51%)
What is United Therapeutics TTM net profit?
The current TTM net income of UTHR is $1.11 B
What is the all time high TTM net income for United Therapeutics?
United Therapeutics all-time high TTM net profit is $1.11 B
What is United Therapeutics TTM net income year-on-year change?
Over the past year, UTHR TTM net profit has changed by +$211.10 M (+23.46%)